EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anatomically Guided Non-Viral CRISPR/Cas9 Delivery in the Eye: Overcoming Barriers for Precision Gene Therapy

Zhixiang Hua, Yang Shen, Xingtao Zhou iD

Pharmaceutics · 24.02.2026 · 18 (3) · 282

DOI: 10.3390/pharmaceutics18030282 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 24.02.2026. Verfasst von Zhixiang Hua und 2 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China for Young Scholars, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: While CRISPR/Cas9 technology offers a revolutionary approach for correcting genetic ocular blindness, efficient and safe delivery remains the primary bottleneck. Traditional viral vectors, despite their efficacy, face challenges regarding cargo size limitations and potential genomic integration risks. Non-viral vectors offer distinct comparative advantages, including large cargo capacity for diverse CRISPR tools and transient expression to minimize off-target effects, but must overcome the eye’s formidable static and dynamic barriers, specifically the corneal epithelium, vitreous humor, and the inner limiting membrane. In this review, we present an anatomically guided framework for non-viral CRISPR/Cas9 delivery, mapping engineering strategies to specific ocular tissue targets. We first delineate the mechanisms of key physiological barriers, including the corneal stroma, aqueous humor circulation, and the vitreous–retina interface. Subsequently, we critically evaluate the latest advancements in non-viral platforms, such as pH-responsive lipid nanoparticles and engineered virus-like particles. The core focus of this review is on site-specific breakthrough strategies: from utilizing mucoadhesive polymers to counteract tear clearance in the cornea to exploiting specialized administration routes, such as suprachoroidal space and subretinal injection, to bypass retinal barriers, and deep-penetrating intravitreal carriers for targeting the photoreceptor-RPE complex. By integrating material science with precise administration routes, this review highlights feasible translational pathways for next-generation, carrier-free, or biomimetic ocular gene editing therapies.

Schlagwörter

Stichwörter der Autor:innen

CRISPR/Cas9anatomical barriersnon-viral deliveryocular gene therapyphysiological barriers

Autor:innen und Institutionen

  • Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
  • NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai 200031, China.
  • Shanghai Engineering Research Centre of Laser and Autostereoscopic 3D for Vision Care, Shanghai 200031, China.
  • Shanghai Research Centre of Ophthalmology and Optometry, Shanghai 200031, China.

ORCID-Profile: Xingtao Zhou

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China for Young Scholars
  • National Natural Science Foundation of China
  • Shanghai Municipal Health Commission
  • the Research Project of Shanghai Municipal Health Commission
  • Research Project of Shanghai Municipal Health Commission

Zitieren

APA

Hua, Z., Shen, Y., & Zhou, X. (2026). Anatomically Guided Non-Viral CRISPR/Cas9 Delivery in the Eye: Overcoming Barriers for Precision Gene Therapy. Pharmaceutics, 18(3), 282. https://doi.org/10.3390/pharmaceutics18030282

Vancouver

Hua Z, Shen Y, Zhou X. Anatomically Guided Non-Viral CRISPR/Cas9 Delivery in the Eye: Overcoming Barriers for Precision Gene Therapy. Pharmaceutics. 2026;18(3):282. doi:10.3390/pharmaceutics18030282

BibTeX
@article{Hua2026,
  author = {Hua, Zhixiang and Shen, Yang and Zhou, Xingtao},
  title = {Anatomically Guided Non-Viral CRISPR/Cas9 Delivery in the Eye: Overcoming Barriers for Precision Gene Therapy},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {282},
  doi = {10.3390/pharmaceutics18030282}
}
Kostenlos starten →